NCT01570478 - A Study in Patients With Asthma | Biotech Hunter

Enrollment

108

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Asthma

Interventions

DRUG

Foster® NEXThaler® 100/6 µg/unit dose

Foster® NEXThaler® (beclomethasone dipropionate 100 µg plus formoterol 6 µg per actuation), 2 inhalations b.i.d. (daily dose of BDP 400 µg plus FF 24 µg)

DRUG

Seretide® Accuhaler® 250/50 µg/actuation

Seretide® Accuhaler® (fluticasone propionate 250 μg plus salmeterol xinafoate 50 μg per actuation), 1 inhalation b.i.d. (daily dose of fluticasone 500 μg plus salmeterol 100 μg)

Trial Locations (1)

43100

Dipartimento Cardio-Polmonare - Azienda Ospedaliero-Universitaria - Padiglione Rasori, Parma

All Listed Sponsors

lead

Chiesi Farmaceutici S.p.A.

INDUSTRY